They noted that SUVmax significantly correlated with the CD8/forkhead box P3 (FOXP3) ratio, an immune-functional marker of tumor-infiltrating lymphocytes (TILs), which are major components of TIME and are substantially related to tumor progression and response to chemotherapy in BC [24]. This evidence concerns the gene CD8A and breast cancer.